@FierceBiotech: Wall Street to keep eye on Vertex data. Story | Follow @FierceBiotech
@JohnCFierce: Speaking of hep C, the BBC does a closeup on Inhibitex's INX-189. Stories | Follow @JohnCFierce
> Vertex, Auxilium and HGS lead Morningstar's top 10 picks for possible biotech acquisition targets this year. Report
> Biovest filed its proposed Plan of Reorganization with the U.S. Bankruptcy Court for the Middle District of Florida, Tampa Division, which will position the company to emerge from Chapter 11 protection this summer as a fully restructured company. Release
> European regulators have given orphan drug status to Aeterna Zentaris' potential ovarian cancer treatment, the Canadian biotechnology company said Monday. Report
> BioInvent and ThromboGenics's partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 in patients with metastatic, treatment-refractory, colorectal and ovarian cancer. BioInvent and ThromboGenics will receive a milestone payment from Roche. Release
> Chinese authorities have fined two drug companies, including one authorized to make swine flu vaccines, for producing substandard rabies shots, state media said Monday. Report
> Eli Lilly will unveil data from 57 studies at the American Society of Clinical Oncology meeting in Chicago, IL, including the latest research results on Alimta and Gemzar, as well as Erbitux with partners Bristol-Myers Squibb and Merck-Serono. Release
> Roxro Pharma announced today that the FDA has approved SPRIX nasal spray for the short-term management of acute moderate to moderately severe pain that requires analgesia at the opioid level. Release
> Six months after Bristol-Myers Squibb wrote a big check to Bothell, WA-based Alder Biopharmaceuticals, the first public glimpse of data from a mid-stage clinical trial of the companies' experimental antibody drug for rheumatoid arthritis appeared online last week. Story
And Finally... David Brigham is taking on a challenge that has stumped biologists, chemists and spider experts across the world: the industrial production of spider silk. Article